User:Wei Peng - Revision history

Wei Peng at 19:44, 8 December 2025

2025-12-08T19:44:05Z

2025-12-08T19:43:36Z

2025-02-04T16:36:31Z

2025-02-04T16:35:25Z

2025-01-18T21:29:42Z

2025-01-03T21:51:37Z

2025-01-03T21:48:39Z

2024-12-18T23:02:57Z

2024-12-18T23:02:13Z

2024-12-18T23:00:25Z

← Older revision		Revision as of 19:44, 8 December 2025
Line 1:		Line 1:
−	[[Image:Wei-Peng.jpeg\|~~200px~~\|right]]	+	[[Image:Wei-Peng.jpeg\|150px\|right]]
	Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.		Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.

← Older revision		Revision as of 19:43, 8 December 2025
Line 1:		Line 1:
−	[[Image:Wei-Peng.jpeg\|~~150px~~\|right]]	+	[[Image:Wei-Peng.jpeg\|200px\|right]]
	Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.		Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.

@@ Line 2: / Line 2: @@
 Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.
-Wei and colleagues discovered that the bacterial effector protein AvrB is an unprecedented glycosyltransferase <cite>Peng2024</cite>. AvrB contains a domain or fold called Fido <cite>Kinch2009</cite>. AvrB catalyzes the transfer of rhamnose from UDP-rhamnose to a threonine residue of its protein substrate in host cells <cite>Peng2024</cite>. '''AvrB is the founding member of glycosyltransferases with Fido fold''' ([[GT138]]).
+Wei and colleagues discovered that the bacterial effector protein AvrB is an unprecedented glycosyltransferase <cite>Peng2024</cite>. AvrB contains a domain or fold called Fido <cite>Kinch2009</cite>. AvrB catalyzes the transfer of rhamnose from UDP-rhamnose to a threonine residue of its protein substrate in host cells <cite>Peng2024</cite>. '''AvrB is the founding member of glycosyltransferases with Fido fold''', belonging to family of [[GT138]].
 Wei contributed to studies on:

← Older revision		Revision as of 16:35, 4 February 2025
Line 1:		Line 1:
−	[[Image:Wei-Peng.jpeg\|~~200px~~\|right]]	+	[[Image:Wei-Peng.jpeg\|150px\|right]]
	Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.		Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.

@@ Line 1: / Line 1: @@
 [[Image:Wei-Peng.jpeg|200px|right]]
-Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. Currently as a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.
+Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. As a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.
 Wei and colleagues discovered that the bacterial effector protein AvrB is an unprecedented glycosyltransferase <cite>Peng2024</cite>. AvrB contains a domain or fold called Fido <cite>Kinch2009</cite>. AvrB catalyzes the transfer of rhamnose from UDP-rhamnose to a threonine residue of its protein substrate in host cells <cite>Peng2024</cite>. '''AvrB is the founding member of glycosyltransferases with Fido fold''' ([[GT138]]).

@@ Line 2: / Line 2: @@
 Wei Peng obtained his Ph.D. at Tsinghua University (Beijing, China) with Prof. Yigong Shi and Prof. Nieng Yan. He was trained as a structural biologist using protein crystallography/cryo-EM and other tools to investigate protein functions. Currently as a postdoctoral scholar with Prof. Kim Orth at UT Southwestern Medical Center (Dallas, USA), he has been focusing on host-pathogen interactions.
-Wei and colleagues discovered that the bacterial effector protein AvrB is an unprecedented glycosyltransferase (with a fold called Fido) <cite>Peng2024</cite>. AvrB catalyzes the transfer of rhamnose from UDP-rhamnose to a threonine residue of its protein substrate in host cells. '''AvrB is the founding member of glycosyltransferases with Fido fold''' ([[GT138]]).
+Wei and colleagues discovered that the bacterial effector protein AvrB is an unprecedented glycosyltransferase <cite>Peng2024</cite>. AvrB has a fold called
 Wei contributed to studies on:
@@ Line 13: / Line 14: @@
 <biblio>
 #Peng2024 pmid=38354245
 </biblio>

← Older revision		Revision as of 23:02, 18 December 2024
Line 5:		Line 5:

	Wei contributed to studies on:		Wei contributed to studies on:
−
	* [[GT138]] ''Pseudomonas syringae'' rhamnosyltransferase '''AvrB''' <cite>Peng2024</cite>		* [[GT138]] ''Pseudomonas syringae'' rhamnosyltransferase '''AvrB''' <cite>Peng2024</cite>